As a salesman, the printing of the marketing materials is kind of a turn on for me! Seriously, once those get printed they will be mailed out to the list of pharmas doing clinical trials as well as general practitioners who specialize in Alzheimers. The week after they get the materials, I as a salesman could follow up with a phone call to talk about it and hopefully set up an appointment to discuss how LymPro would fit in with screening patients in their clinical trials. LymPro is 1) Less invasive, 2) Cheaper, & 3) More accurate than Amivid. This is where the rubber meets the road.
Enough of this scientific laboratory language, it's time to start selling the hell out of LymPro!!! That's going to start in November. Revenues will start flowing in January and February.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links